Royal Bank Of Canada Seelos Therapeutics, Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.66 - $1.22 $132 - $244	-200 Reduced 10.53%	1,699 $2,000
Q1 2023 May 15, 2023	SELL	$0.59 - $1.04 $366 - $646	-622 Reduced 24.67%	1,899 $1,000
Q4 2022 Feb 14, 2023	SELL	$0.66 - $259.46 $19 - $7,783	-30 Reduced 1.18%	2,521 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.65 - $278.68 $1,347 - $577,703	2,073 Added 433.68%	2,551 $3,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $2,834 - $5,168	-5,558 Reduced 92.08%	478 $0
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $13,914 - $28,326	-16,565 Reduced 73.29%	6,036 $5,000
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $17,009 - $25,461	10,698 Added 89.88%	22,601 $36,000
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $11,299 - $19,322	6,686 Added 128.16%	11,903 $29,000
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $13,772 - $32,971	5,217 New	5,217 $14,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.